Improving diabetes management by eliminating out-of-pocket medication costs
DP20-002, Louisiana Experiment to Address Diabetes: Zero-Dollar Copayment (LEAD-ZDC) for Improving Disease Management
This study is looking at how not having to pay copayments for some diabetes medications can help people with Type 2 diabetes in Louisiana stick to their treatment plans and feel healthier.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10852790 on NIH RePORTER |
What this research studies
This research investigates how removing copayments for certain diabetes medications can improve adherence to treatment among patients with Type 2 diabetes in Louisiana. By collaborating with various stakeholders, including healthcare providers and community organizations, the project aims to assess the impact of this policy change on medication adherence and overall health outcomes. The study will focus on patients insured by Blue Cross and Blue Shield of Louisiana, examining how reduced costs can lead to better management of diabetes and related health issues.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Type 2 diabetes who are fully insured by Blue Cross and Blue Shield of Louisiana.
Not a fit: Patients who are uninsured or have insurance plans that do not cover the medications involved in the study may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for patients with Type 2 diabetes by enhancing medication adherence through reduced financial barriers.
How similar studies have performed: Previous research has shown that reducing out-of-pocket costs for medications can lead to improved adherence and health outcomes, suggesting that this approach may be effective.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Shi, Lizheng — Tulane University of Louisiana
- Study coordinator: Shi, Lizheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.